regenerative medicine
ISCT announces support of FDA’s new framework for regenerative medicine
The International Society for Cellular Therapy (ISCT) has stated its support of the US Food and Drug Administration’s (FDA’s) new comprehensive Regenerative Medicine Policy Framework. more
Partnership formed for regenerative medicines
The CGT Catapult has signed a Memorandum of Understanding (MoU) with the FIRM in Japan, demonstrating a shared ambition to accelerate research and commercialisation of regenerative medicine. more
Sartorius and Science to award a prize for regenerative medicine and cell therapy
The Sartorius and Science Prize for Regenerative Medicine & Cell Therapy is focused towards scientists advancing research within the relevant fields, with the winner receiving $25,000 in prize money and being published in Science magazine more
Regenerative medicine bringing pharma and medtech closer together
Regenerative medicine is redefining medical technology synergies by combining stem cell technology with tissue engineering. more
Avita Medical launches regenerative medicine range
Avita Medical, a regenerative medicine company specialising in new treatments for wounds and skin defects, has announced the launch of ReGenerCell for chronic wounds and ReNovaCell for repigmentation more
Quick determination of cell culture surfaces
Orla Protein Technologies has developed an efficient means of determining the optimum protein surface required for different cell culture applications and research tasks. more
CiMaas and PharmaCell enter collaboration
CiMaas, a developer of cellular immunotherapy for cancer, and PharmaCell, a contract manufacturer for cellular therapies and regenerative medicine in Europe, are collaborating in the clinical development of CiMaas’ products. more
AMSBIO launches exosomes for regenerative medicine research
A new range of human exosomes has been launched by AMSBIO for regenerative medicines research. Derived from placental and adipose stem cells, they are ideally suited for wound healing, stem cell differentiation and tissue regeneration applications. more
New CSO furthers Plasticell's regenerative medicine expertise
Cell therapies developer Plasticell has recruited Dr. Aaron Chuang chief scientific officer (CSO). Dr. Chuang takes on responsibility for preclinical therapeutic programmes and scientific oversight of collaborations and alliances, as well as external more
Regenerative medicine market is expected to reach $67.6 billion, global, by 2020
The immense potential of these medicines in repairing or regenerating diseased organs is the major reason for intensive focus on research and development in this field. more
Can regenerative medicine be the cure for cancer and other deadly diseases?
Frost & Sullivan's Global Regenerative Medicine Market finds approval rates and clinical activity buzz point to regenerative medicine being attractive for investors. more
